XBIO 8-K 2026-09-23
Xenetic Biosciences, Inc. (XBIO) 8-K dated 2026-09-23 — accession 0001683168-26-007340.
Xenetic Biosciences, Inc. (XBIO) is a biotechnology company listed on US.
Xenetic Biosciences, Inc. filed a 8-K on 2026-09-23. Accession 0001683168-26-007340.
This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported XBIO revenue for 2025-12-31 was $3.0M. Net income was -$2.7M. Revenue was up 19.0% from 2024-12-31 to 2025-12-31. XBIO currently screens at market cap $5.7M.
Not investment advice. The XBIO SEC hub lists recent forms. The stock page is the research view.